Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$71.24 - $85.35 $40,393 - $48,393
567 New
567 $48,000
Q2 2023

Aug 14, 2023

SELL
$80.84 - $89.45 $94,744 - $104,835
-1,172 Reduced 87.92%
161 $13,000
Q1 2023

May 12, 2023

BUY
$72.75 - $90.6 $71,367 - $88,878
981 Added 278.69%
1,333 $110,000
Q4 2022

Feb 14, 2023

BUY
$73.85 - $86.14 $25,995 - $30,321
352 New
352 $27,000
Q2 2022

Aug 15, 2022

SELL
$49.27 - $66.08 $15,618 - $20,947
-317 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$43.77 - $63.22 $3,764 - $5,436
86 Added 37.23%
317 $20,000
Q4 2021

Feb 11, 2022

BUY
$49.55 - $74.59 $11,446 - $17,230
231 New
231 $12,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.02B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.